Chemed Corporation (NYSE:CHE) Receives Average Rating of “Hold” from Brokerages

Shares of Chemed Corporation (NYSE:CHE) have received a consensus rating of “Hold” from the six ratings firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $530.75.

CHE has been the topic of several recent analyst reports. Royal Bank Of Canada increased their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer upped their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th.

Chemed Price Performance

Shares of Chemed stock opened at $545.55 on Thursday. The company’s fifty day simple moving average is $473.28 and its two-hundred day simple moving average is $438.37. Chemed has a 12-month low of $365.20 and a 12-month high of $551.68. The firm has a market cap of $7.13 billion, a PE ratio of 27.40, a price-to-earnings-growth ratio of 2.04 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts expect that Chemed will post 23.18 EPS for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s payout ratio is 12.05%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares in the company, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,537 shares of company stock valued at $1,782,654 in the last quarter. 3.33% of the stock is currently owned by insiders.

Institutional Trading of Chemed

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Legacy Wealth Asset Management LLC increased its position in shares of Chemed by 25.8% during the second quarter. Legacy Wealth Asset Management LLC now owns 3,056 shares of the company’s stock worth $1,423,000 after acquiring an additional 626 shares during the period. Sunburst Financial Group LLC raised its position in shares of Chemed by 12.0% in the 2nd quarter. Sunburst Financial Group LLC now owns 812 shares of the company’s stock worth $378,000 after acquiring an additional 87 shares in the last quarter. First Heartland Consultants Inc. lifted its position in shares of Chemed by 14.5% during the second quarter. First Heartland Consultants Inc. now owns 1,404 shares of the company’s stock valued at $654,000 after buying an additional 178 shares during the last quarter. GAMMA Investing LLC lifted its position in Chemed by 149.0% during the second quarter. GAMMA Investing LLC now owns 620 shares of the company’s stock valued at $289,000 after acquiring an additional 371 shares during the last quarter. Finally, Somerset Trust Co purchased a new stake in shares of Chemed during the 2nd quarter valued at $228,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.